Clorox (NYSE:CLX) Stock Price Expected to Rise, UBS Group Analyst Says

Clorox (NYSE:CLX) had its target price lifted by investment analysts at UBS Group from $96.00 to $100.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s price target indicates a potential upside of 4.02% from the stock’s previous close.

Several other equities analysts have also recently weighed in on the stock. Jefferies Financial Group cut their target price on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Royal Bank Of Canada decreased their price target on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. Barclays dropped their price objective on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a report on Friday, May 1st. Morgan Stanley cut their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a report on Friday, July 10th. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus price target of $103.47.

Clorox Stock Down 2.6%

NYSE CLX opened at $96.13 on Thursday. The stock’s 50 day moving average is $94.59 and its 200 day moving average is $104.01. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. Clorox has a 12 month low of $84.70 and a 12 month high of $132.03. The stock has a market cap of $11.62 billion, a PE ratio of 15.61, a P/E/G ratio of 0.47 and a beta of 0.54.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the firm posted $1.45 EPS. The company’s revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Research analysts predict that Clorox will post 5.52 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Pierre R. Breber acquired 5,000 shares of Clorox stock in a transaction on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.63% of the stock is owned by insiders.

Hedge Funds Weigh In On Clorox

Institutional investors and hedge funds have recently modified their holdings of the stock. Haverford Trust Co increased its stake in shares of Clorox by 2.8% in the fourth quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock worth $310,000 after acquiring an additional 84 shares during the last quarter. Field & Main Bank raised its holdings in shares of Clorox by 3.3% during the fourth quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after acquiring an additional 100 shares in the last quarter. Golden State Wealth Management LLC boosted its position in Clorox by 28.2% during the fourth quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock valued at $46,000 after purchasing an additional 100 shares during the last quarter. Kestra Private Wealth Services LLC grew its stake in Clorox by 1.8% in the first quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock valued at $617,000 after purchasing an additional 104 shares in the last quarter. Finally, Johnson Financial Group Inc. grew its stake in Clorox by 3.1% in the third quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock valued at $451,000 after purchasing an additional 109 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.